Carregant...
Assessment of Abdominal Pain Through Global Outcomes and Recent FDA Recommendations in Children. Are We Ready For Change?
OBJECTIVES: Irritable bowel syndrome is a multi-symptom construct with abdominal pain (AP) acting as the driving symptom of patient reported severity. The FDA considers a greater than 30% decrease in AP as satisfactory improvement, but this has not been validated in children. We investigated the cor...
Guardat en:
| Publicat a: | J Pediatr Gastroenterol Nutr |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4641447/ https://ncbi.nlm.nih.gov/pubmed/23857339 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPG.0b013e3182a20764 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|